IQVIA (IQV) Just Drew A New Artisan Partners Bet On AI And Resilience
IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026
Is IQVIA Holdings (IQV) Resilient to AI Concerns?
IQVIA Holdings' Q2 2026 Earnings: What to Expect
Hardman Johnston Large Cap Equity Holds Firm on IQVIA Holdings (IQV). Here’s Why
Why Is IQVIA (IQV) Stock Soaring Today
Baird Maintains Outperform on IQVIA Holdings, Raises Price Target to $249
Does Slower Growth at IQVIA Holdings (IQV) Challenge Its Core Data‑Driven Pharma Enablement Story?
Morgan Stanley sees writing on wall for key drug research stocks
Morgan Stanley Downgrades IQVIA Holdings (IQV)
Morgan Stanley favors Charles River Over IQVIA in CRO sector reset
IQVIA (IQV): Buy, Sell, or Hold Post Q1 Earnings?
Morgan Stanley Downgrades IQVIA Holdings to Equal-Weight, Lowers Price Target to $200
Global Healthcare Infrastructure Strengthens IQV Amid Weak Liquidity
Q1 Earnings Roundup: IQVIA (NYSE:IQV) And The Rest Of The Drug Development Inputs & Services Segment
IQVIA Debt Refinance And EPS Upgrade Reshape Long Term Risk Profile
IQVIA (IQV) Up 3.2% Since Last Earnings Report: Can It Continue?
IQVIA Announces Pricing of Senior Notes
IQVIA Holdings Inc. (IQV) Presents at Jefferies Global Healthcare Conference 2026 Transcript
IQVIA Announces Offering of Senior Notes
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.